VP, R&D and General Manager, CoolSculpting
Brad Hauser has been Vice President, R&D and General Manager for CoolSculpting at Allergan since ZELTIQ was acquired in April 2017. He joined the CoolSculpting team in 2013, as Vice President of Product and Clinical Strategy, and later became Senior Vice President of Research and Development. Previous to ZELTIQ, he has held multiple roles in the aesthetic industry, including Executive Vice President of Commercial Operations for Cutera, Director of Research and Development at Medicis and Managing Director of Product and Clinical Marketing at Solta Medical. Mr. Hauser received his Bachelor of Arts in Human Biology from Stanford University.